Treprostinil Boosts Exercise Capacity in Severe Thromboembolic Pulmonary HTN Treprostinil Boosts Exercise Capacity in Severe Thromboembolic Pulmonary HTN

Subcutaneous treprostinil appears safe and improves exercise capacity in patients with severe non-operable chronic thromboembolic pulmonary hypertension (CTEPH), according to results from a phase 3 randomized controlled trial.Reuters Health Information

Source: Medscape Medical News Headlines - January 2, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news